USD10
TAK Shares
About Takeda Pharmaceutical CoTakeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada.
USD10
TAK Shares
About Takeda Pharmaceutical CoTakeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada.
Stats
TRADING WINDOW
Closed
OPENS AT
Not enough data
MARKET CAP
$62.84B
OPEN PRICE
$19.67
LOW (1Y)
$12.99
HIGH (1Y)
$19.89
LOW (24H)
$19.56
HIGH (24H)
$19.71
VOLUME (24H)
$2.83M
35.49%
Price history
Time | Price | Change |
|---|---|---|
Today | $19.67 | 0.00% |
1 Day | $19.67 | 0.00% |
1 Week | $18.76 | |
1 Month | $19.93 | |
1 Year | $14.08 |
Past performance is not a reliable indicator of future results.
Discover more
Explore other stocks
Popular prediction markets
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.